Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

Gill, Steven S., Patel, Nikunj K., Hotton, Gary R., O'Sullivan, Karen, McCarter, Renée, Bunnage, Martin, Brooks, David J., Svendsen, Clive N. +1 more·2003·Nature Medicine
DOI 10.1038/nm850

Cited by (1,000)

Items 701–800 of 1,000

  1. Pharmacological MRI (phMRI) Monitoring of Treatment in Hemiparkinsonian Rhesus Monkeys
    Liming Luan, Feng Ding, Yi Ai, Anders H. Andersen, Peter Hardy, Eric Forman, Greg A. Gerhardt, Don Marshall Gash, Richard Grondin, Zhiming Zhang · 2008 · Cell Transplantation
  2. HSV vector-delivery of GDNF in a rat model of PD: partial efficacy obscured by vector toxicity
    Christelle Monville, Eduardo Torres, Eleri Thomas, Cinzia G. Scarpini, Justna Muhith, Jeff Lewis, Jaquie Finn, Chris Smith, Shijie Cai, Stacey Efstathiou et al. · 2004 · Brain Research
  3. CGP 56999A, a GABAB receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway
    S.J. Enna, Scott A. Reisman, John A. Stanford · 2006 · Neuroscience Letters
  4. Aerobic exercise-induced changes in fluid biomarkers in Parkinson’s disease
    Nijee Luthra, Niyati Mehta, Miranda J. Munoz, Giamila Fantuzzi, Guillaume J. Lamotte, Jacob M. Haus, Nikolaus R. McFarland, Malú G. Tansey, Paulina González-Latapí, Gabriela Caraveo et al. · 2025 · npj Parkinson s Disease
  5. Biomaterial approaches to gene therapies for neurodegenerative disorders of the CNS.
    B. Newland, Eilís Dowd, A. Pandit · 2013 · Biomaterials Science
  6. Towards a Better Treatment Option for Parkinson’s Disease: A Review of Adult Neurogenesis
    Parisa Farzanehfar · 2016 · Neurochemical Research
  7. Advancing gene therapies, methods, and technologies for Parkinson’s Disease and other neurological disorders
    Massimo S. Fiandaca, Russell R. Lonser, James Bradley Elder, Mirosław Ząbek, Krystof S. Bankiewicz · 2020 · Neurologia i Neurochirurgia Polska
  8. Cytokine-, Neurotrophin-, and Motor Rehabilitation-Induced Plasticity in Parkinson’s Disease
    Gabriella Policastro, Matteo Brunelli, Michèle Tinazzi, Cristiano Chiamulera, Dwaine F. Emerich, Giovanna Paolone · 2020 · Neural Plasticity
  9. Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF
    O. Meagan Littrell, Ann‐Charlotte Granholm, Greg A. Gerhardt, Heather A. Boger · 2013 · Pharmacology Biochemistry and Behavior
  10. Neurotrophic factors for the treatment of Parkinson's disease
    Matthew J. Chiocco, Brandon K. Harvey, Yun Wang, Barry J. Hoffer · 2007 · Parkinsonism & Related Disorders
  11. Evaluation of the physical and in vitro protective activity of three synthetic peptides derived from the pro- and mature GDNF sequence
    Kristen A. Kelps, Jadwiga T. Turchan-Cholewo, Erin R. Hascup, Tiffany L. Taylor, Don Marshall Gash, Greg A. Gerhardt, Luke H. Bradley · 2011 · Neuropeptides
  12. Effect of GDNF-releasing biodegradable microspheres on the function and the survival of intrastriatal fetal ventral mesencephalic cell grafts
    Anne Clavreul, Laurence Sindji, Anne Aubert‐Pouëssel, Jean‐Pierre Benoît, Philippe Meneï, Claudia N. Montero‐Menei · 2006 · European Journal of Pharmaceutics and Biopharmaceutics
  13. Penetration, diffusion, and uptake of recombinant human α-l-iduronidase after intraventricular injection into the rat brain
    Pavel V. Belichenko, Patricia Dickson, Merry B. Passage, Steve Jungles, William Cary Mobley, Emil Kakkis · 2005 · Molecular Genetics and Metabolism
  14. Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivo
    David B. O’Sullivan, Patrick T. Harrison, Aideen M. Sullivan · 2010 · Journal of Neural Transmission
  15. Catecholaminergic neuron survival: getting hooked on GDNF
    Carlos F. Ibáñez · 2008 · Nature Neuroscience
  16. Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor
    Elisa Garbayo, Eduardo Ansorena, José Luis Lanciego, Marta Aymerich, María J. Blanco‐Prieto · 2007 · International Journal of Pharmaceutics
  17. Neuroprotection for Parkinson’s disease
    Peter A. LeWitt · 2006 · Springer eBooks
  18. Understanding the Potential of Genome Editing in Parkinson’s Disease
    David Arango, Amaury Bittar, Natalia P. Esmeral, Camila Ocasión, Carolina Muñoz-Camargo, Juan C. Cruz, Luis H. Reyes, Natasha I. Bloch · 2021 · International Journal of Molecular Sciences
  19. GFR α‐1 receptor expression in the aging nigrostriatal and mesoaccumbens pathways
    Brandon Scott Pruett, Michael F. Salvatore · 2010 · Journal of Neurochemistry
  20. Proteome of brain glia: The molecular basis of diverse glial phenotypes
    Mithilesh Kumar Jha, Jae‐Hong Kim, Kyoungho Suk · 2013 · PROTEOMICS
  21. Treatment of Early Parkinson’s Disease
    Tanya Simuni, Kelly E. Lyons, Rajesh Pahwa, Robert A. Hauser, Cynthia L. Comella, Lawrence W. Elmer, Daniel A. Weintraub · 2009 · European Neurology
  22. Effects of glial cell line-derived neurotrophic factor on microRNA expression in a 6-hydroxydopamine-injured dopaminergic cell line
    Li Li, Huizhen Chen, Fangfang Chen, Feng Li, Meng Wang, Li Wang, Yun-Qing Li, Dianshuai Gao · 2013 · Journal of Neural Transmission
  23. Parkinson's disease and growth factors – are they the answer?
    Roger A. Barker · 2009 · Parkinsonism & Related Disorders
  24. Controlled release of glial cell line-derived neurotrophic factor from poly(ε-caprolactone) microspheres
    Andrew M. Agbay, Nima Khadem Mohtaram, Stephanie Michelle Willerth · 2014 · Drug Delivery and Translational Research
  25. Prospect of cell therapy for Parkinson's disease
    Jeanne Adiwinata Pawitan · 2011 · Anatomy & Cell Biology
  26. Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression
    Lizheng Wang, Zixuan Wang, Rui Zhu, Jinpeng Bi, Xinyao Feng, Wenmo Liu, Jiaxin Wu, Haihong Zhang, Hui Wu, Wei Kong et al. · 2017 · PLoS ONE
  27. Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data
    Napoleon Torres-Martinez, Jenny Molet, Cécile Moro, John Mitrofanis, Alim Louis Benabid · 2017 · International Journal of Molecular Sciences
  28. Chronic 2-Fold Elevation of Endogenous GDNF Levels Is Safe and Enhances Motor and Dopaminergic Function in Aged Mice
    Giorgio Turconi, Jaakko J. Kopra, Vootele Võikar, Natalia Kulesskaya, Carolina Vilenius, Petteri T. Piepponen, Jaan‐Olle Andressoo · 2020 · Molecular Therapy — Methods & Clinical Development
  29. STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5
    Jayanth Anantha, Susan R. Goulding, Sean L. Wyatt, Ruth M. Concannon, Louise Collins, Aideen M. Sullivan, Gerard W. O’Keeffe · 2020 · iScience
  30. Eicosanoid receptor subtype‐mediated opposing regulation of TLR‐stimulated expression of astrocyte glial‐derived neurotrophic factor
    Xianwu Li, Eiron Cudaback, RICHARD M. BREYER, Kathleen S. Montine, Christopher Dirk Keene, Thomas Jude Montine · 2012 · The FASEB Journal
  31. Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons
    Fanny Schmidt, Gael Le Douaron, Pierre Champy, Majid Amar, Blandine Séon‐Méniel, Rita Raisman‐Vozari, Bruno Figadère · 2010 · Bioorganic & Medicinal Chemistry
  32. Sorting Protein-related Receptor SorLA Controls Regulated Secretion of Glial Cell Line-derived Neurotrophic Factor
    Zhao Geng, Feng-Yi Xu, Shuhong Huang, Zhe-Yu Chen · 2011 · Journal of Biological Chemistry
  33. Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson’s disease
    Agustín Anastasía, Gabriel A. de Erausquin, José Wojnacki, Daniel Hugo Mascó · 2007 · Journal of Neurochemistry
  34. Emerging drugs for Parkinson’s disease
    John C. Morgan, Kapil D. Sethi · 2006 · Expert Opinion on Emerging Drugs
  35. Towards New Therapies for Parkinson's Disease
    David Isaac Finkelstein · 2011 · InTech eBooks
  36. Potentiation of in vivo neuroprotection by BclXL and GDNF co-expression depends on post-lesion time in deafferentiated CNS neurons
    Z Shevtsova, Ibrahim Malik, M. Garrido, Ulrike Schöll, Mathias Bähr, Sebastian Kügler · 2006 · Gene Therapy
  37. Surgical therapy for Parkinson’s disease
    Alim‐Louis Benabid, Stéphan Chabardès, Éric Seigneuret, Valérie Fraix, Paul Krack, Pierre Pollak, R. Xia, Bradley A. Wallace, Fabien Sauter · 2006 · Springer eBooks
  38. Expectations and challenges in the therapeutic use of neurotrophic factors
    Paul T. Kotzbauer, David M. Holtzman · 2006 · Annals of Neurology
  39. Double-Blind, Placebo-Controlled Trials for Surgical Interventions in Parkinson Disease
    C. Warren Olanow · 2005 · Archives of Neurology
  40. Assessing the risk of a necessary harm
    Olivier Rascol · 2005 · Neurology
  41. Gene Therapy for Misfolding Protein Diseases of the Central Nervous System
    Waldy San Sebastián, Lluı́s Samaranch, Adrian P. Kells, John Forsayeth, Krystof S. Bankiewicz · 2013 · Neurotherapeutics
  42. Focused ultrasound enhances transgene expression of intranasal hGDNF DNA nanoparticles in the sonicated brain regions
    Amirah E.-E. Aly, Tao Sun, Yongzhi Zhang, Zejun Li, Margee J. Kyada, Qingxi Ma, Linas Padegimas, Ozge Sesenoglu‐Laird, Mark J. Cooper, Nathan Judson McDannold et al. · 2023 · Journal of Controlled Release
  43. Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies
    Raimo K. Tuominen, Juho‐Matti Renko · 2024 · Basic & Clinical Pharmacology & Toxicology
  44. Heterotopic Mucosal Grafting Enables the Delivery of Therapeutic Neuropeptides Across the Blood Brain Barrier
    Benjamin Saul Bleier, Richie E. Kohman, Kevin Guerra, Angela L. Nocera, Shreshtha B Ramanlal, Armine H. Kocharyan, William T. Curry, Xue Han · 2015 · Neurosurgery
  45. BDNF-Gene Transfected Schwann Cell-Assisted Axonal Extension and Sprouting on New PLA-PPy Microfiber Substrates.
    F. Gisbert Roca, F. André, Jorge Más Estellés, Manuel Monleón Pradas, L. Mir, C. Martínez-Ramos · 2021 · Macromolecular Bioscience
  46. Rola czynników neurotroficznych w procesach regeneracji układu nerwowego
    Bogusław Machaliński, Piotr Łażewski-Banaszak, Elżbieta Dąbkowska, Edyta Paczkowska, Monika Gołąb-Janowska, Przemysław Nowacki · 2012 · Neurologia i Neurochirurgia Polska
  47. Methods of reactivation and reprogramming of neural stem cells for neural repair
    Zuojun Tian, Qiuge Zhao, Sangita Biswas, Wenbin Deng · 2017 · Methods
  48. Jia-Jian-Di-Huang-Yin-Zi decoction exerts neuroprotective effects on dopaminergic neurons and their microenvironment
    Jingsi Zhang, Zhennian Zhang, Wen Zhang, Xiangting Li, Ting Wu, Tingting Li, Min Cai, Zhonghai Yu, Jun Yong Xiang, Ding-Fang Cai · 2018 · Scientific Reports
  49. The first cysteine-rich domain of the receptor GFRα1 stabilizes the binding of GDNF
    Heidi VIRTANEN, Jianmin Yang, Maxim M. Bespalov, Jukka O. Hiltunen, Veli‐Matti Leppänen, Nisse Kalkkinen, Adrian Goldman, Märt Saarma, Pia Runeberg‐Roos · 2005 · Biochemical Journal
  50. Gene therapy for Parkinson's disease
    Patricia A. Lawlor, Matthew J. During · 2004 · Expert Reviews in Molecular Medicine
  51. The future of cell therapies in the treatment of Parkinson's disease
    Rocío Laguna Goya, Wei‐Li Kuan, Roger A. Barker · 2007 · Expert Opinion on Biological Therapy
  52. Imaging in cell-based therapy for neurodegenerative diseases
    Deniz Kirik, Nathalie Breysse, Tomas Björklund, Laurent Besret, Philippe Hantraye · 2005 · European Journal of Nuclear Medicine and Molecular Imaging
  53. Dual modulation on glial cells by tetrahydroxystilbene glucoside protects against dopamine neuronal loss
    Yanzhen Zhou, Guoqing Wang, Daidi Li, Yanying Wang, Qin Wu, Jingshan Shi, Feng Zhang · 2018 · Journal of Neuroinflammation
  54. Serum glial cell line-derived neurotrophic factor (GDNF) a potential biomarker of executive function in Parkinson’s disease
    Shuyan Tong, Rui-Wen Wang, Qian Li, Yi Liu, Xiao-Yan Yao, Deqin Geng, Dianshuai Gao, Chao Ren · 2023 · Frontiers in Neuroscience
  55. Functional neurochemistry of the basal ganglia
    Pershia Samadi, Claude Rouillard, Paul J. Bédard, Thérèse Di Paolo · 2007 · Handbook of clinical neurology
  56. Increased brain bio-distribution and chemical stability and decreased immunogenicity of an engineered variant of GDNF
    Rosamund C. Smith, Linda M. O’Bryan, Pamela J. Mitchell, Donmienne Leung, Mahmoud Ghanem, Jonathan Matthew Wilson, Jeff C. Hanson, Sandra Sossick, Jane Cooper, Lihua Huang et al. · 2015 · Experimental Neurology
  57. Effects of GDNF-Transfected Marrow Stromal Cells on Rats with Intracerebral Hemorrhage
    Li Deng, Xiaoqing Gao, Guangbi Fan, Chaoxian Yang · 2019 · Journal of Stroke and Cerebrovascular Diseases
  58. Molecular targets for endogenous glial cell line-derived neurotrophic factor modulation in striatal parvalbumin interneurons
    Daniel Enterría‐Morales, Natalia López‐González del Rey, Javier Blesa, Ivette López‐López, Sarah Gallet, Vincent Prévot, José López‐Barneo, Xavier d’Anglemont de Tassigny · 2020 · Brain Communications
  59. The Effects of Deep Brain Stimulation of the Subthalamic Nucleus on Vascular Endothelial Growth Factor, Brain-Derived Neurotrophic Factor, and Glial Cell Line-Derived Neurotrophic Factor in a Rat Model of Parkinson’s Disease
    Katharina Faust, Peter Vajkoczy, Bai Xi, Daniel Harnack · 2020 · Stereotactic and Functional Neurosurgery
  60. The tumor suppressor PTEN regulates motor responses to striatal dopamine in normal and Parkinsonian animals
    Mihaela A. Stavarache, Sergei A. Musatov, Marlon A. McGill, Mary Vernov, Michael G. Kaplitt · 2015 · Neurobiology of Disease
  61. Are growth factors the answer?
    Shilpa Ramaswamy, Jeffrey H. Kordower · 2009 · Parkinsonism & Related Disorders
  62. Molecular mechanism of the neurotrophic effect of GDNF on DA neurons: role of protein kinase CK2
    Chih-Chang Chao, Cheng H. Chiang, Yun‐Li Ma, Eminy H.Y. Lee · 2005 · Neurobiology of Aging
  63. Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice
    Vandana Zaman, Matthew E. Nelson, Greg A. Gerhardt, Bärbel Rohrer · 2004 · Experimental Neurology
  64. Direct brain infusion of glial cell line derived neurotrophic factor in Parkinson disease
    2003 · Nature
  65. Exploring the diversity of biological processes regulated by glial cell line-derived neurotrophic factor, a pleiotropic molecule with therapeutic potential
    Cristina Porcari, Stefano Cattaneo, Lucia Crippa, Michele Simonato, Barbara Bettegazzi · 2025 · Frontiers in Physiology
  66. Neuritin-overexpressing transgenic mice demonstrate enhanced neuroregeneration capacity and improved spatial learning and memory recovery after ischemia-reperfusion injury
    Kexing Wan, Fuxiu Mao, Qiongqiong Li, Limin Wang, Zhiguo Wei, Ping Wang, Xinhua Liao, Mengsi Xu, Jin Huang, Zemin Pan et al. · 2020 · Aging
  67. Neurotrophic Factors in Glaucoma and Innovative Delivery Systems
    Fabiana Mallone, Marta Sacchetti, Alice Bruscolini, Luca Scuderi, Marco Marenco, Alessandro Lambìase · 2020 · Applied Sciences
  68. UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib
    Bin Chen, Md. Mahmudul Hasan, Hengsen Zhang, Qing Zhai, A. S. M. Waliullah, Yashuang Ping, Chi Zhang, Soho Oyama, Mst. Afsana Mimi, Yuna Tomochika et al. · 2023 · Biomedicines
  69. Continuous intraputamenal convection-enhanced delivery in adult rhesus macaques
    Xiaotong Fan, Brian D. Nelson, Yi Ai, David K. Stiles, Don Marshall Gash, Peter Hardy, Zhiming Zhang · 2015 · Journal of neurosurgery
  70. Growth Factors in Olfaction
    Robert Irwin Henkin · 2011 · Springer eBooks
  71. Upregulation of Glutathione Peroxidase-1 Expression and Activity by Glial Cell Line–Derived Neurotrophic Factor Promotes High-Level Protection of PC12 Cells Against 6-Hydroxydopamine and Hydrogen Peroxide Toxicities
    Ehsan Gharib, Mossa Gardaneh, Sahar Shojaei · 2013 · Rejuvenation Research
  72. Gene Therapy with Viral Vectors
    Douglas J. Jolly · 2003 · BioProcessing Journal
  73. Regulatable Lentiviral Hematopoietic Stem Cell Gene Therapy in a Mouse Model of Parkinson's Disease
    Guo Ge, Cang Chen, Michael J. Guderyon, Jingwei Liu, Zhixu He, Yanni Yu, Robert A. Clark, Senlin Li · 2018 · Stem Cells and Development
  74. Surgical Management of Parkinson's Disease: Update and Review
    Y. Chao, Gang Li, Z.L. Na, W Ming, W.S. Zhong, Wenguang MIAN · 2007 · Interventional Neuroradiology
  75. Lentivirus-mediated delivery of sonic hedgehog into the striatum stimulates neuroregeneration in a rat model of Parkinson disease
    Yi Zhang, Wei-Ren Dong, Suiqun Guo, Shu Zhao, Suifen He, Lihua Zhang, Yinjuan Tang, Haihong Wang · 2014 · Neurological Sciences
  76. GENE AND CELL DELIVERY TO THE DEGENERATED STRIATUM
    Robert Mark Richardson, Paul Larson, Krystof S. Bankiewicz · 2008 · Neurosurgery
  77. The design of clinical trials for cell transplantation into the central nervous system
    Pierre Césaro · 2004 · NeuroRx
  78. Induced Cognitive Impairments Reversed by Grafts of Neural Precursors: A Longitudinal Study in a Macaque Model of Parkinson's Disease
    Florence Wianny, Kwamivi Dzahini, Karim Fifel, Charles R. E. Wilson, Agnieszka Bernat, Virginie Dolmazon, Pierre Misery, Camille Lamy, Pascale Giroud, Howard Michael Cooper et al. · 2022 · Advanced Science
  79. Transcranial Magnetic Stimulation Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease and the Related Mechanisms: A Mini-Review
    Yi Wu, Xuebing Cao, Weiqi Zeng, Heng Zhai, Xiaoqian Zhang, Xiaoman Yang, Chi Cheng, Jialing Wang, Xiao-mei Yang, Yan Kang Xu · 2021 · Frontiers in Neurology
  80. Differential expression of RET and GDNF family receptor, GFR-α1, between striatum and substantia nigra following nigrostriatal lesion: A case for diminished GDNF-signaling
    Ella Anle Kasanga, Yoonhee Han, Walter Navarrete, Robert McManus, Marla K. Shifflet, Caleb Parry, Arturo Barahona, Fredric P. Manfredsson, Vicki A. Nejtek, Jason R. Richardson et al. · 2023 · Experimental Neurology
  81. Cryogel microcarriers for sustained local delivery of growth factors to the brain
    Abrar Hakami, Kaushik Narasimhan, Giulia Comini, Julian Thiele, Carsten Werner, Eilís Dowd, Ben Newland · 2024 · Journal of Controlled Release
  82. Convection enhanced delivery of different molecular weight tracers of gadolinium-tagged polylysine
    Peter Hardy, Dan Keeley, Greg Schorn, Eric Forman, Yi Ai, Ramakrishna Venugopalan, Zhiming Zhang, Luke H. Bradley · 2013 · Journal of Neuroscience Methods
  83. Endogenous Repair by the Activation of Cell Survival Signalling Cascades during the Early Stages of Rat Parkinsonism
    Nga-Ping Lui, Liang‐Wei Chen, Wing‐Ho Yung, YS Chan, Ken Kin Lam Yung · 2012 · PLoS ONE
  84. Zebrafish GDNF and its co-receptor GFRα1 activate the human RET receptor and promote the survival of dopaminergic neurons in vitro
    Tuulia Saarenpää, Konstantin Kogan, Yulia A. Sidorova, Arun Kumar Mahato, Igor Tascón, Heidi Kaljunen, Li-Ying Yu, Jukka Kallijärvi, Jaana Jurvansuu, Märt Saarma et al. · 2017 · PLoS ONE
  85. Neuroprotective cyclopentenone prostaglandins up-regulate neurotrophic factors in C6 glioma cells
    Yoko Hirata, Kyoji Furuta, Masaaki Suzuki, Kentaro Oh‐hashi, Yoshihito Ueno, Kazutoshi Kiuchi · 2012 · Brain Research
  86. Neurotropic growth factors and glycosaminoglycan based matrices to induce dopaminergic tissue formation
    Katja Schurig, Andrea Zieris, Andreas Hermann, Uwe Freudenberg, Sabine Heidel, Milauscha Grimmer, Alexander Storch, Carsten Werner · 2015 · Biomaterials
  87. Dynamic changes in dopamine neuron function after DNSP-11 treatment: Effects in vivo and increased ERK 1/2 phosphorylation in vitro
    Joshua L. Fuqua, O. Meagan Littrell, Martin Lundblad, Jadwiga T. Turchan-Cholewo, Lina G. Abdelmoti, Emilia Galperin, Luke H. Bradley, Wayne A. Cass, Don Marshall Gash, Greg A. Gerhardt · 2014 · Peptides
  88. Stem cells in development of therapeutics for Parkinson's disease: A perspective
    Jiajie Xi, Su‐Chun Zhang · 2008 · Journal of Cellular Biochemistry
  89. GDNF in Parkinson's disease: The perils of post-hoc power
    James Matcham, Michael McDermott, Anthony Edward Lang · 2007 · Journal of Neuroscience Methods
  90. Neurogenesis in Diseases of the Central Nervous System
    Wendy Phillips, Andrew W. Michell, Roger A. Barker · 2006 · Stem Cells and Development
  91. Convection-Enhanced Delivery in Children: Techniques and Applications
    Kristian Aquilina, Anupam Chakrapani, Lucinda Carr, Manju A. Kurian, Darren R. Hargrave · 2022 · Advances and technical standards in neurosurgery
  92. Restorative cell and gene therapies for Parkinson's disease
    Roger A. Barker, Anders Björklund · 2023 · Handbook of clinical neurology
  93. High-frequency stimulation of the globus pallidus interna nucleus modulates GFRα1 gene expression in the basal ganglia
    Duncun Ho, Yong Chee Tan, Jiayi Tan, Heng‐Phon Too, Wai Hoe Ng · 2013 · Journal of Clinical Neuroscience
  94. Translational research for Parkinson׳s disease: The value of pre-clinical primate models
    Romina Aron Badin, Marta Vadori, Emanuele Cozzi, Philippe Hantraye · 2015 · European Journal of Pharmacology
  95. Neurotrophic Effects of Growth/Differentiation Factor 5 in a Neuronal Cell Line
    André Toulouse, Grace C. Collins, Aideen M. Sullivan · 2011 · Neurotoxicity Research
  96. Restorative neuroscience: concepts and perspectives
    M Meyer, AD Ducray, HR Widmer · 2008 · Swiss Medical Weekly
  97. Maximizing Local Access to Therapeutic Deliveries in Glioblastoma. Part II: Arborizing Catheter for Convection-Enhanced Delivery in Tissue Phantoms
    Egleide Y. Elenes, Christopher G. Rylander · 2017 · Codon Publications eBooks
  98. Nanoformulation: A Useful Therapeutic Strategy for Improving Neuroprotection and the Neurorestorative Potential in Experimental Models of Parkinson's Disease
    José Vicente Lafuente, Catalina Requejo, Alejandro Carrasco, Harkaitz Bengoetxea · 2017 · International review of neurobiology
  99. Small molecule of sphingosine as a rescue of dopaminergic cells: A cell therapy approach in neurodegenerative diseases therapeutics
    Shima Tavakol, Elham Hoveizi, Behnaz Tavakol, Fereshteh Azedi, Somayeh Ebrahimi‐Barough, Peyman Keyhanvar, Mohammad Taghi Joghataei · 2019 · Journal of Cellular Physiology
  100. Photodynamic Opening of the Blood–Brain Barrier Using Different Photosensitizers in Mice
    OXANA V. SEMYACHKINA-GLUSHKOVSKAYA, Ekaterina G. Borisova, Vanya N. Mantareva, Иван Ангелов, Ivelina Eneva, Andrey V. Terskov, Мамедова Айсель Тофик-Кызы, Alexander A. Shirokov, Alexander P. Khorovodov, Maria Klimova et al. · 2019 · Applied Sciences